TriplePoint Venture Growth BDC Corp. sets the price for a public offering of common stock

MENLO PARK, Calif.–(BUSINESS WIRE)–TriplePoint Venture Growth BDC Corp. (NYSE: TPVG) (the “Company”) announced today that it has priced a bought offering of 3,750,000 common shares at a public price of $13.75 per share for aggregate gross proceeds of approximately $51,562,500, before deducting underwriting commission and rebates and estimated offering expenses. The public offering is expected to close on or about August 9, 2022, subject to customary closing conditions. In connection with the offer, the Company has granted to the underwriters of the offer an option to purchase up to an additional 562,500 shares of the common shares of the Company.

The Company expects to initially use all of the net proceeds of this offering to repay outstanding debt borrowed under its credit facility. However, by re-borrowing the initial repayments under the credit facility, the Company intends to use the funds to make investments in accordance with its investment objectives and strategies, to pay its operating expenses and other cash, and for general corporate purposes.

Wells Fargo Securities, Morgan Stanley, Keefe, Bruyette & Woods, A Stifel company, UBS Investment Bank and Goldman Sachs & Co. LLC, are acting as joint bookrunners for the offering. Deutsche Bank Securities is acting as lead manager and Compass Point, Ladenburg Thalmann, Oppenheimer & Co., Piper Sandler and KeyBanc Capital Markets are acting as co-offering managers.

A shelf registration statement relating to the securities to be issued pursuant to the offering is filed with and has been declared effective by the Securities and Exchange Commission (the “SEC”). The offering may only be made by means of a prospectus and related prospectus supplement, copies of which may be obtained, when available, from any of the following investment banks: Wells Fargo Securities, LLC, Attention: Equity Syndicate Department, 500 West 33rd Street, New York, New York, 10001, at (800) 326-5897 or email a request to [email protected]; Morgan Stanley & Co. LLC – Attn: Prospectus Department – 180 Varick Street, 2nd Floor – New York, NY 10014; Keefe, Bruyette & Woods, Inc., Attn: Capital Markets, 787 Seventh Avenue, 4th Floor, New York, NY 10019, Telephone: 1-800-966-1559; UBS Securities LLC, Prospectus Department, 1285 Avenue of the Americas, New York, NY 10019, or by calling (888) 827-7275, or by email: [email protected]; Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, phone: 1-866-471-2526, fax: 212-902-9316 or by emailing [email protected] .email.gs. com;, or by calling toll-free at (866) 803-9204.

The preliminary prospectus supplement, dated August 4, 2022, and the accompanying prospectus, dated May 26, 2021, each filed with the SEC, contain a description of these matters and other important information about the Company and should be read carefully before investing. Investors are advised to carefully consider the investment objectives, risks and charges and expenses of the Company before investing.

This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities of this offer or any other securities, and there will be no sale of these securities or any other securities mentioned in this press release in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About TriplePoint Venture Growth BDC Corp.

The company was formed to expand the venture capital growth-stage business segment of TriplePoint Capital LLC, the world’s leading provider of financing at all stages of technology, life sciences and other development. high-growth companies backed by a select group of venture capitalists. The Company’s investment objective is to maximize its total shareholder return primarily in the form of current income and, to a lesser extent, capital appreciation by lending primarily with warrants to growth-stage companies . The Company is an externally managed, non-diversified, closed-end investment company which has elected to be regulated as a business development company under the Investment Companies Act 1940, as amended.

Forward-looking statements

Statements included herein may constitute “forward-looking statements” that relate to future events or our future performance or financial condition. These statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Actual results and conditions may differ materially from those in the forward-looking statements due to a number of factors, including those described from time to time in our filings with the SEC. The Company undertakes no obligation to update any forward-looking statements made herein.

Comments are closed.